Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations
Background: Lipoprotein(a) is positively related to cardiovascular events in patients with coronary artery disease (CAD). Given that lipoprotein(a) has a prothrombotic effect, prolonged dual antiplatelet therapy (DAPT) might have a beneficial effect on reducing ischemic events in patients with eleva...
Main Authors: | Kongyong Cui, Hao-Yu Wang, Dong Yin, Chenggang Zhu, Weihua Song, Hongjian Wang, Lei Jia, Dong Zhang, Chenxi Song, Lei Feng, Kefei Dou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.807925/full |
Similar Items
-
How Do Lipoprotein(a) Concentrations Affect Clinical Outcomes for Patients With Stable Coronary Artery Disease Who Underwent Different Dual Antiplatelet Therapy After Percutaneous Coronary Intervention?
by: Kongyong Cui, et al.
Published: (2022-05-01) -
Uric Acid Levels, Number of Standard Modifiable Cardiovascular Risk Factors, and Prognosis in Patients With Coronary Artery Disease: A Large Cohort Study in Asia
by: Kongyong Cui, et al.
Published: (2023-10-01) -
Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis
by: Kongyong Cui, et al.
Published: (2022-01-01) -
Validation of the DAPT score in large-scale consecutive and contemporary patients population in the real world
by: Guofeng Gao, et al.
Published: (2021-11-01) -
Time Trends of Ventricular Reconstruction and Outcomes among Patients with Left Ventricular Thrombus and Aneurysms
by: Boqun Shi, et al.
Published: (2022-12-01)